Fetal Anemia: Causes, Diagnosis and Treatment Options

·

Share

Fetal anemia means the unborn baby has too few red blood cells or too little hemoglobin to carry enough oxygen around its body. The most common cause is red cell alloimmunization, in which the mother’s antibodies attack the baby’s red cells, but infections such as parvovirus B19, bleeding from the baby into the mother’s circulation, and inherited blood conditions can also be responsible. It is detected mainly with a Doppler ultrasound of a blood vessel in the baby’s brain, and severe cases can be treated before birth with an intrauterine blood transfusion.

Fetal anemia is uncommon, but as a specialist in haematology I often meet parents worried about it after an antibody result or an ultrasound finding. This guide explains the causes, how it is diagnosed, and what treatment involves.

What Is Fetal Anemia?

Red blood cells carry oxygen from the placenta to every developing organ. In fetal anemia, the baby has a lower than normal level of red blood cells, so its tissues receive less oxygen.

A fetus compensates at first by pumping blood faster and making more red cells, including in the liver and spleen. When anemia is severe, the heart can start to fail, and fluid leaks into the baby’s tissues and body cavities. This serious state is called hydrops fetalis.

Normal fetal hemoglobin rises steadily through pregnancy, so doctors judge anemia against the expected value for the baby’s gestational age rather than a single fixed number.

Causes and Risk Factors

Fetal anemia has three broad mechanisms: red cells are destroyed too quickly, too few are made, or blood is lost.

Mechanism Cause How it leads to anemia
Destruction (immune) Red cell alloimmunization (e.g., anti-D, anti-Kell, anti-c) Maternal antibodies cross the placenta and destroy fetal red cells
Reduced production Parvovirus B19 infection The virus infects red cell precursors in the fetal marrow and liver
Reduced production (Kell) Anti-Kell antibodies Also suppress the making of new red cells, not only their destruction
Blood loss Fetomaternal hemorrhage Fetal blood leaks across the placenta into the mother’s circulation
Blood loss / imbalance Twin-to-twin transfusion or related twin conditions One twin loses blood to the other through shared placental vessels
Inherited Alpha thalassemia major, some red cell enzyme or membrane disorders Faulty hemoglobin or fragile red blood cells

How Rh Disease Develops

If an Rh-negative mother carries an Rh-positive baby, some fetal blood may enter her circulation, often at delivery, miscarriage, or after abdominal trauma. Her immune system can then make anti-D antibodies. The first pregnancy is usually unaffected, but in a later Rh-positive pregnancy those antibodies cross the placenta and break down the baby’s red cells. This is why the disease more often affects second and subsequent pregnancies.

Signs and Symptoms

The mother usually feels nothing different, and early fetal anemia causes no visible signs. It is typically found through antibody screening in pregnancy or during an ultrasound scan.

Findings that may point to anemia include:

  • Raised blood flow speed in the fetal brain on Doppler ultrasound
  • An enlarged fetal heart, liver, or spleen
  • Extra fluid around the heart, lungs, or abdomen, or skin swelling (signs of hydrops)
  • A thickened placenta or increased amniotic fluid
  • Reduced fetal movements in more advanced cases

How Fetal Anemia Is Diagnosed

Maternal Antibody Screening

Every pregnant woman has her blood group and antibody screen checked early in pregnancy. If a significant antibody is found, its level (titer) is monitored. The father’s blood type, or a test of fetal DNA in the mother’s blood, can show whether the baby is actually at risk.

Middle Cerebral Artery Doppler

The key test is a middle cerebral artery peak systolic velocity (MCA-PSV) measurement. Anemic blood is thinner and the fetal heart pumps harder, so blood flows faster through this brain artery. Results are expressed as multiples of the median (MoM) for gestational age, and a value above 1.5 MoM suggests moderate to severe anemia. This non-invasive scan has largely replaced amniocentesis for monitoring.

Fetal Blood Sampling

When Doppler results suggest significant anemia, a specialist can take blood directly from the umbilical cord under ultrasound guidance. This procedure, called cordocentesis, confirms the hemoglobin level and is usually done at the same time as a transfusion. Other tests look for causes, such as parvovirus serology in the mother or a Kleihauer test to measure fetal blood in her circulation. Wider hematological investigation may be needed if an inherited disorder is suspected.

Treatment and Management

Treatment depends on how severe the anemia is and how far along the pregnancy has progressed.

  • Monitoring: mild anemia, or a pregnancy at risk but not yet affected, is followed with regular Doppler scans, often every one to two weeks.
  • Intrauterine transfusion: for moderate to severe anemia, compatible donor blood is transfused into the umbilical vein under ultrasound guidance to restore red blood cell levels. It may need repeating every few weeks until delivery, and it is performed only in specialist fetal medicine centers.
  • Timing of delivery: babies are often delivered a little early, in a unit with neonatal intensive care, once the risks of prematurity are lower than the risks of continuing treatment.
  • After birth: newborns may need phototherapy for jaundice, further transfusions, or, occasionally, an exchange transfusion, and are followed for late anemia over the first weeks and months.

Complications and Prevention

Without treatment, severe fetal anemia can progress to hydrops fetalis, heart failure, and stillbirth. Babies born with significant red cell breakdown can develop high bilirubin levels, which in severe cases can damage the brain.

Rh disease is largely preventable. Rh-negative mothers are offered anti-D immunoglobulin during pregnancy and after delivery of an Rh-positive baby, and after events such as miscarriage, bleeding, or abdominal injury. Anti-D prevents the mother from forming her own antibodies. There is no equivalent vaccine for most other antibodies, so screening and early referral are the main safeguards.

Key Takeaways

  • Fetal anemia is most often caused by maternal red cell antibodies, especially anti-D.
  • Parvovirus B19, fetomaternal hemorrhage, twin conditions, and inherited disorders are other causes.
  • MCA Doppler ultrasound is the main non-invasive screening test.
  • Intrauterine transfusion can treat severe anemia before birth.
  • Anti-D immunoglobulin prevents most cases of Rh disease.

Frequently Asked Questions

Is fetal anemia caused by the mother being anemic?

Usually not. Mild iron deficiency in the mother rarely causes significant anemia in the baby, because the placenta prioritizes the fetus’s iron supply. Fetal anemia usually has a specific cause, such as antibodies or infection.

Is intrauterine transfusion safe?

It is a well-established procedure in experienced centers, and for a severely anemic baby its benefits far outweigh the risks. Risks include bleeding from the cord, infection, and triggering early labor, which your specialist will discuss with you.

Will my next pregnancy be affected?

If the cause was red cell antibodies, future pregnancies with an antigen-positive baby are likely to be affected, often earlier. Parvovirus infection, by contrast, generally does not recur. Speak with your specialist before your next pregnancy.

Can babies with fetal anemia grow up healthy?

Yes. With timely monitoring and treatment, most babies go on to develop normally, although they need close follow-up in the first months of life.

Written by
Haematology, Platelet Biology
Contact [email protected] severin_sonia Inserm U1048 I2MC September 24, 2020 A close relationship between adipocytes and megakaryocytes: a link with obesity Judith Cosemans holds a PhD degree (2009) in platelet biology, which focused on the dynamic regulation of thrombus stability. As a postdoc, she further developed flow chamber technology as a compatible alternative for experimental animal models of arterial thrombosis. As…
View Full Profile →
Web Admin Avatar